Rodent models of treatment-induced motor complications in Parkinson's disease

Angela Cenci Nilsson, Elisabet Ohlin

Research output: Contribution to journalArticlepeer-review

28 Citations (SciVal)


Treatment-induced motor complications represent a major clinical problem in Parkinson's disease (PD). Pharmacological dopamine (DA) replacement with l-dopa causes motor fluctuations and abnormal involuntary movements (dyskinesia) in the vast majority of the patients. Intrastriatal grafts of embryonic dopaminergic neurons can cause dyskinesia too, as shown by clinical trials of neural transplantation in PD. Animals models of these complications can be produced in rats and mice in which the nigrostriatal DA pathway has been severely damaged. Rodent models allow investigators to explore mechanistic hypotheses at the cellular and molecular level. Moreover, the rat model of L-dopa-induced abnormal involuntary movements shows both face validity and predictive validity relative to the corresponding disorder in primates, and provides a cost effective tool to evaluate novel antidyskinetic interventions. This article reviews the strategies that have been used to reproduce different motor complications of PD treatment in rodents, and comments on their range of applicability.

Original languageEnglish
Pages (from-to)S13-7
JournalParkinsonism and Related Disorders
Volume15 Suppl 4
Publication statusPublished - 2009 Dec

Subject classification (UKÄ)

  • Neurosciences


  • Animals
  • Brain Tissue Transplantation
  • Disease Models, Animal
  • Dyskinesia, Drug-Induced
  • Humans
  • Levodopa
  • Mice
  • Motor Skills Disorders
  • Parkinson Disease
  • Rats
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review


Dive into the research topics of 'Rodent models of treatment-induced motor complications in Parkinson's disease'. Together they form a unique fingerprint.

Cite this